VM Montori, M Fernandez-Balsells - Annals of Internal Medicine, 2009 - Am Coll Physicians Some diabetes guidelines set low glycemic control goals for patients with type 2 diabetes mellitus
(such as a hemoglobin A 1c level as low as 6.5% to 7.0%) to avoid or delay complications. Our
review and critique of recent large randomized trials in patients with type 2 diabetes ... Cited by 10 - Related articles - All 3 versions
- ►spendocrinologia.org.pe [PDF] KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, … - The Lancet, 2009 - Elsevier We selected five prospective randomised controlled trials of 33 040 participants to assess the
effect of an intensive glucose-lowering regimen on death and cardiovascular outcomes compared
with a standard regimen. We gathered information about events of non-fatal myocardial ... Cited by 44 - Related articles - All 42 versions
A Siebenhofer, K Jeitler, TR Pieber, K Horvath - The Lancet, 2009 - Elsevier First, with their inclusion criteria, Ray and colleagues created a potpourri of ingredients, freely
mixing studies that compared different glucose-lowering intensities with studies in which the
same intensity level was used in both treatment groups. Second, there were serious flaws ... Related articles - All 8 versions
BDL Bereznicki - ecite.utas.edu.au The articles in this SWIGS are independentlv researched anel compiled by PSA commissioned
authors and peer reviewed. ... After reading this article, you should be able to: ... It Outline the
current management goals for people with type 2 diabetes is Australia Related articles - View as HTML
ZH Israili - American Journal of Therapeutics, 2009 - pdfs.journals.lww.com There is a rising worldwide prevalence of diabetes, especially type 2 diabetes mellitus
(T2DM), which is one of the most challenging health problems in the 21st century. The associated
complications of diabetes, such as cardiovascular disease, peripheral vascular disease, ... Related articles - All 4 versions
DM Mann, M Woodward, F Ye, M Krousel- … - Archives of Internal …, 2009 - Am Med Assoc Successful reduction of cardiovascular disease (CVD) risk among people with diabetes mellitus
is increasingly reliant on combination pharmacotherapy targeting its major risk factors, especially
hypertension and high cholesterol level. 1 The impact of tight hyperglycemia control on ... Related articles - All 3 versions
SI McFarlane, JR Sowers - Therapy, 2009 - Future Medicine Cardiovascular disease (CVD) is the major cause of morbidity and mortality in people with
diabetes, and represents up to 80% of premature death in this patient population [1,2]. Traditional
CVD risk factors in the diabetic population include hypertension, insulin resistance, ... Related articles - All 3 versions
D Extraction, Q Assessment - acponline.org The prevalence of type 2 diabetes is increasing globally (1-3) . Epidemiologic evidence indicates
that diabetes is a major risk factor for cardiovascular disease (CVD), and recent data suggest
that the CVD burden attributable to diabetes is on the rise (4-7) . Clinical trials have ... Related articles - Cached
T Laubscher, L Regier, B Jensen - Canadian Family Physician, 2009 - 171.66.125.180 Tom is a 72-year-old man who has type 2 DM, hypertension, hyperlipidemia, and stable
angina. He has had type 2 DM for about 14 years; until recently, his blood glucose (BG) levels
were well controlled with combinations of oral hypoglycemic agents (OHAs), diet, and ... Related articles - All 4 versions
MH Dominiczak - Current Opinion in Lipidology, 2009 - journals.lww.com The European Action on Secondary and Primary Preven- tion by Intervention to Reduce Events
(EUROASPIRE) I, II and III surveys were conducted in 1995, 1999–2000 and 2006–2007, respectively
[1 ]. Their aim was to gain insight into the status of preventive cardiology practice. In the ... Related articles - All 4 versions
